Session Type: Poster Session C
Session Time: 1:00PM-3:00PM
Background/Purpose: Suboptimal adherence to anti-osteoporotic medications presents a growing social and economic concern. Yet, it is unclear what patients’ perspectives and experiences are regarding medication use, and how these vary across phases of adherence, patients’ identities and various anti-osteoporotic medications. We aimed to describe patients’ perspectives and experiences of medication use in osteoporosis, to inform person-centred interventions that improve adherence and patient outcomes.
Methods: Databases (MEDLINE, Embase, PsycINFO and CINAHL) were searched for qualitative studies reporting on the perspectives and experiences of adults (≥18 years) with osteoporosis and/or osteopenia, and regarding anti-osteoporotic medications, in any language until February, 2022. Inductive thematic analysis was performed. Multiple investigators, including a consumer with lived experience of osteoporosis, have been integral to data analysis.
Results: From 35 articles with 853 adults with osteoporosis or osteopenia, four themes (with sub-themes) were identified:
Conclusion: Patients’ perceptions of vulnerability, confidence in healthcare relationships, attitudes towards change and accessible support systems can influence their commitment to medication-taking. Offering tailored education may empower patients to make informed decisions regarding treatment risks and benefits, and participate confidently in shared-decision making. Greater time and consistent communication devoted to patients’ concerns and expectations can foster a supportive environment that may alleviate the fear and uncertainty associated with adjusting to medications. Continued emphasis on treatment benefits and avenues to voice emerging concerns may promote long-term adherence and health outcomes. Further studies evaluating adherence-improving strategies through the consumers’ lens are vital to drive the development of more informed, person-centred interventions and optimise physical, psychosocial and functional outcomes.
To cite this abstract in AMA style:Dey S, Spratt G, Koobasi M, Vleeskens C, El-Haddad C, Kelly A. Patients’ Perspectives and Experiences of Medication Use in Osteoporosis – a Qualitative Systematic Review and Thematic Synthesis [abstract]. Arthritis Rheumatol. 2022; 74 (suppl 9). https://acrabstracts.org/abstract/patients-perspectives-and-experiences-of-medication-use-in-osteoporosis-a-qualitative-systematic-review-and-thematic-synthesis/. Accessed .
« Back to ACR Convergence 2022
ACR Meeting Abstracts - https://acrabstracts.org/abstract/patients-perspectives-and-experiences-of-medication-use-in-osteoporosis-a-qualitative-systematic-review-and-thematic-synthesis/